The IPO Buzz: Aspen Neuroscience (ASPE) Prices IPO at $15 – Low End

Aspen Neuroscience (ASPE), a biotech developing a stem cell therapy to treat patients with Parkinson’s Disease, priced its IPO at $15.00 – the low end of its range – and sold 9.375 million shares – the number in the prospectus – to raise $140.63 million on Thursday night, Oct. 29, 2026. The San Diego-based biotech's IPO had been marketed at a price range of $15.00 to $17.00. Aspen Ne..

Read more October 30, 2026

IPO Calendar

Company Symbol proposed Lead Managers Shares (Millions) Price Low Price High Est. $ Volume Expected to Trade SCOOP Rating Rating Change
Aspen Neuroscience ASPE Leerink Partners/Piper Sandler/Stifel/UBS Investment Bank/Oppenheimer & Co. 9.4 15.00 15.00 $ 140.6 mil 10/30/2026 Priced S/O S/O
Bambusa Therapeutics BBTX BofA Securities/Evercore ISI/UBS Investment Bank/Cantor 10.6 16.00 16.00 $ 168.8 mil 10/30/2026 Priced S/O S/O
OPay Limited OPAY Citigroup/Deutsche Bank Securities/Standard Bank/CICC 16.0 19.00 19.00 $ 304.0 mil 10/30/2026 Priced S/O S/O
Read more

Last 100 IPOs - October 29, 2026

Number of IPOs priced : 100
Number Up: 44
Number Down: 54
Number Unchanged: 2
Percentage Change From Issue Price: 2.09%
Percentage Change for The Nasdaq Composite 35.22%

2026 IPO Scorecard - October 29, 2026

Number of IPOs priced (Excluding 154 units) : 135
Number Up: 53
Number Down: 80
Number Unchanged: 2
Total Return From Issue Price: -0.73%
The Nasdaq Composite Index YTD % Change 35.22%